Finally, our results confirmed that reduced Dicer expression was associated with poor survival in VHL-deficient ccRCC patients, consistent with the prognosis associated with reduced Dicer expression in lung, ovarian, and breast cancer patients [43–45]. This evidence concerns the gene VHL and breast carcinoma.